About us
QUALIblood is located in Liège, at the LégiaPark.
Our lab owns and develops innovative technologies in the field of blood analyses allowing to offer a portfolio of more than 600 biomarkers.
Exploring Research Expertise
The teams aim at sharing their expertise in research achievement and protocol design in order to reach the client objective at each stage of his project.
The team recently finished the development of a new biomarker allowing to predict and prevent the risk of venous thromboembolism (VTE), the nAPCsr
Partner with us for high-quality solutions and efficient drug development.
Contact us today to unlock the full potential of your research.
Our terms of sale are provided here